These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services. AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227 [TBL] [Abstract][Full Text] [Related]
3. Accelerated approval regulations may need overhaul, panel suggests. Finkelstein JB J Natl Cancer Inst; 2005 Dec; 97(24):1802-4. PubMed ID: 16368938 [No Abstract] [Full Text] [Related]
4. FDA approves Gleevec for leukemia treatment. FDA Consum; 2001; 35(4):6. PubMed ID: 11692893 [No Abstract] [Full Text] [Related]
5. FDA approves new drug for specific type of advanced breast cancer. Mayo Clin Womens Healthsource; 2007 Oct; 11(10):3. PubMed ID: 18418907 [No Abstract] [Full Text] [Related]
6. FDA approves sorafenib for patients with inoperable liver cancer. Lang L Gastroenterology; 2008 Feb; 134(2):379. PubMed ID: 18242200 [No Abstract] [Full Text] [Related]
7. DOXIL approved by FDA. AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446 [No Abstract] [Full Text] [Related]
8. FDA approves new PCP drug. Food and Drug Administration. AIDS Alert; 1995 Aug; 10(8):108. PubMed ID: 11362680 [TBL] [Abstract][Full Text] [Related]
11. Should the FDA be the doctor of last resort? DeVita VT Nat Clin Pract Oncol; 2005 Sep; 2(9):423. PubMed ID: 16264991 [No Abstract] [Full Text] [Related]
12. Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products. Rock EP; Scott JA; Kennedy DL; Sridhara R; Pazdur R; Burke LB J Natl Cancer Inst Monogr; 2007; (37):27-30. PubMed ID: 17951228 [TBL] [Abstract][Full Text] [Related]
13. Significant FDA approvals in 1999. McGinnis TJ Am Fam Physician; 2000 Apr; 61(8):2531-3. PubMed ID: 10794586 [No Abstract] [Full Text] [Related]
14. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Kane RC; Farrell AT; Sridhara R; Pazdur R Clin Cancer Res; 2006 May; 12(10):2955-60. PubMed ID: 16707588 [TBL] [Abstract][Full Text] [Related]
15. Patient group seeks overhaul of FDA clinical trial system in court. Hede K J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242 [No Abstract] [Full Text] [Related]
16. Obstacles at the FDA? Delap RJ Sci Am; 1997 Jan; 276(1):8. PubMed ID: 8972611 [No Abstract] [Full Text] [Related]
17. FDA approves Hep C drugs. AIDS Alert; 2004 Jun; 19(6):71. PubMed ID: 15272452 [No Abstract] [Full Text] [Related]
18. FDA notifications. FDA approves new Kaletra formulation. AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722 [No Abstract] [Full Text] [Related]
19. FDA notifications. FDA approves generic foscarnet sodium injection. AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563 [No Abstract] [Full Text] [Related]